Peter C Gøtzsche

Summary

Affiliation: Det Nordiske Cochrane Center
Country: Denmark

Publications

  1. pmc House dust mite control measures in the management of asthma: meta-analysis
    P C Gøtzsche
    Nordic Cochrane Centre, Rigshospitalet, Department 7112, DK 2200 Copenhagen N, Denmark
    BMJ 317:1105-10; discussion 1110. 1998
  2. ncbi request reprint Is screening for breast cancer with mammography justifiable?
    P C Gøtzsche
    Nordic Cochrane Centre, Rigshospitalet, Department 7112, Copenhagen, Denmark
    Lancet 355:129-34. 2000
  3. ncbi request reprint [Misleading report concerning our work on mammographic screening]
    Peter C Gøtzsche
    Det Nordiske Cochrane Center, København
    Lakartidningen 99:75-6. 2002
  4. ncbi request reprint On the benefits and harms of screening for breast cancer
    Peter C Gøtzsche
    The Nordic Cochrane Centre, Rigshospitalet, Dept 7112, Blegdamsvej 9, DK 2100 Copenhagen Ø, Denmark
    Int J Epidemiol 33:56-64; discussion 69-73. 2004
  5. pmc Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study
    Karsten Juhl Jørgensen
    Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 København Ø, Denmark
    BMJ 328:148. 2004
  6. doi request reprint Screening for breast cancer with mammography
    Peter C Gøtzsche
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    Cochrane Database Syst Rev 6:CD001877. 2013
  7. ncbi request reprint [Information about breast cancer screening presented on websites is biased and insufficient--a secondary publication]
    Karsten Juhl Jørgensen
    H S Rigshospitalet, Det Nordiske Cochrane Center, København
    Ugeskr Laeger 167:174-8. 2005
  8. pmc Sponsors' participation in conduct and reporting of industry trials: a descriptive study
    Andreas Lundh
    The Nordic Cochrane Centre, Rigshospitalet, Dept 7811, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    Trials 13:146. 2012
  9. pmc Citations of scientific results and conflicts of interest: the case of mammography screening
    Kristine Rasmussen
    Department 7811, Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark
    Evid Based Med 18:83-9. 2013
  10. ncbi request reprint The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials
    Lise L Gluud
    The Cochrane Hepato Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
    Am J Gastroenterol 100:2431-5. 2005

Detail Information

Publications68

  1. pmc House dust mite control measures in the management of asthma: meta-analysis
    P C Gøtzsche
    Nordic Cochrane Centre, Rigshospitalet, Department 7112, DK 2200 Copenhagen N, Denmark
    BMJ 317:1105-10; discussion 1110. 1998
    ..To determine whether patients with asthma who are sensitive to mites benefit from measures designed to reduce their exposure to house dust mite antigen in the home...
  2. ncbi request reprint Is screening for breast cancer with mammography justifiable?
    P C Gøtzsche
    Nordic Cochrane Centre, Rigshospitalet, Department 7112, Copenhagen, Denmark
    Lancet 355:129-34. 2000
    ..We therefore reviewed the methodological quality of the mammography trials and an influential Swedish meta-analysis, and did a meta-analysis ourselves...
  3. ncbi request reprint [Misleading report concerning our work on mammographic screening]
    Peter C Gøtzsche
    Det Nordiske Cochrane Center, København
    Lakartidningen 99:75-6. 2002
  4. ncbi request reprint On the benefits and harms of screening for breast cancer
    Peter C Gøtzsche
    The Nordic Cochrane Centre, Rigshospitalet, Dept 7112, Blegdamsvej 9, DK 2100 Copenhagen Ø, Denmark
    Int J Epidemiol 33:56-64; discussion 69-73. 2004
  5. pmc Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study
    Karsten Juhl Jørgensen
    Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 København Ø, Denmark
    BMJ 328:148. 2004
    ..To investigate whether information on mammographic screening presented on websites by interest groups is balanced, is independent of source of funding, and reflects recent findings...
  6. doi request reprint Screening for breast cancer with mammography
    Peter C Gøtzsche
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    Cochrane Database Syst Rev 6:CD001877. 2013
    ..A variety of estimates of the benefits and harms of mammographic screening for breast cancer have been published and national policies vary...
  7. ncbi request reprint [Information about breast cancer screening presented on websites is biased and insufficient--a secondary publication]
    Karsten Juhl Jørgensen
    H S Rigshospitalet, Det Nordiske Cochrane Center, København
    Ugeskr Laeger 167:174-8. 2005
  8. pmc Sponsors' participation in conduct and reporting of industry trials: a descriptive study
    Andreas Lundh
    The Nordic Cochrane Centre, Rigshospitalet, Dept 7811, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    Trials 13:146. 2012
    ..We investigated sponsors' involvement in the conduct and reporting of industry-sponsored trials...
  9. pmc Citations of scientific results and conflicts of interest: the case of mammography screening
    Kristine Rasmussen
    Department 7811, Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark
    Evid Based Med 18:83-9. 2013
    ..This led to a heated debate and a recent review of the evidence by UK experts intended to be independent...
  10. ncbi request reprint The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials
    Lise L Gluud
    The Cochrane Hepato Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
    Am J Gastroenterol 100:2431-5. 2005
    ..To examine the association between the impact factor and characteristics of hepatobiliary randomized clinical trials...
  11. pmc General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis
    Lasse T Krogsbøll
    Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
    BMJ 345:e7191. 2012
    ..To quantify the benefits and harms of general health checks in adults with an emphasis on patient-relevant outcomes such as morbidity and mortality rather than on surrogate outcomes...
  12. pmc Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study
    Andreas Lundh
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    PLoS Med 7:e1000354. 2010
    ..We investigated industry-supported trials' influence on journal impact factors and revenue...
  13. doi request reprint Why mammography screening has not lived up to expectations from the randomised trials
    Peter C Gøtzsche
    Dept 3343, The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark
    Cancer Causes Control 23:15-21. 2012
    ..We also believe it is more important to reduce the incidence of cancer than to detect it 'early.' Avoiding getting screening mammograms reduces the risk of becoming a breast cancer patient by one-third...
  14. pmc Overdiagnosis in organised mammography screening in Denmark. A comparative study
    Karsten J Jørgensen
    The Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMC Womens Health 9:36. 2009
    ..We quantified overdiagnosis in the Danish mammography screening programme, which is uniquely suited for this purpose, as only 20% of the Danish population has been offered organised mammography screening over a long time-period...
  15. ncbi request reprint Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review
    Julie Pildal
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    Clin Infect Dis 39:38-46. 2004
    ..61 (95% CI, 0.50-0.73). Because high-quality trials failed to demonstrate a reduction in mortality, polyclonal immunoglobulin should not be used for treatment of sepsis except in randomized clinical trials...
  16. ncbi request reprint [Freedom of expression and editorial independence: Four firings and a Kafkanian process]
    Peter C Gøtzsche
    Rigshospitalet, Afsnit 3343, Det Nordiske Cochrane Center, DK 2100 København Ø
    Ugeskr Laeger 170:1537-8. 2008
  17. ncbi request reprint The debate on breast cancer screening with mammography is important
    Peter C Gøtzsche
    Nordic Cochrane Centre, H S Rigshospitalet, Copenhagen, Denmark
    J Am Coll Radiol 1:8-14. 2004
  18. pmc The breast screening programme and misinforming the public
    Peter C Gøtzsche
    The Nordic Cochrane Centre, Copenhagen, Denmark
    J R Soc Med 104:361-9. 2011
    ..Concerns about over-diagnosis have not been addressed either and official documents still downplay this most important harm of breast cancer screening...
  19. pmc Breast cancer mortality in organised mammography screening in Denmark: comparative study
    Karsten Juhl Jørgensen
    The Nordic Cochrane Centre, Rigshospitalet, University of Copenhagen, Denmark
    BMJ 340:c1241. 2010
    ....
  20. ncbi request reprint Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications
    Emma Maund
    Nordic Cochrane Centre, Rigshospitalet Dept 7811, Copenhagen, Denmark
    BMJ 348:g3510. 2014
    ....
  21. ncbi request reprint Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study
    Emma Maund
    Nordic Cochrane Centre, Rigshospitalet Department 7811, Copenhagen, Denmark
    BMJ 348:g3555. 2014
    ..To assess the effects of coding and coding conventions on summaries and tabulations of adverse events data on suicidality within clinical study reports...
  22. pmc Content of invitations for publicly funded screening mammography
    Karsten Juhl Jørgensen
    Nordic Cochrane Centre, Rigshospitalet Department 7112, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMJ 332:538-41. 2006
  23. ncbi request reprint What is publication?
    Peter C Gøtzsche
    Nordic Cochrane Centre, HS Rigshospitalet, DK 2100 København Ø, Denmark
    Lancet 368:1854-6. 2006
  24. pmc Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study
    Julie Bolette Brix Bindslev
    The Nordic Cochrane Centre, Rigshospitalet Department 7811, Blegdamsvej 9, DK 2100, Copenhagen Ø, Denmark
    BMC Med Ethics 14:19. 2013
    ..However, not all conflicts of interest are disclosed. Using a public available disclosure list we determined the prevalence and underreporting of conflicts of interest among authors of clinical guidelines on drug treatments...
  25. ncbi request reprint The benefits and harms of screening for cancer with a focus on breast screening
    John Brodersen
    Department and Research Unit of General Practice, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark
    Pol Arch Med Wewn 120:89-94. 2010
    ....
  26. pmc Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends
    Karsten Juhl Jørgensen
    The Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMJ 339:b2587. 2009
    ..To estimate the extent of overdiagnosis (the detection of cancers that will not cause death or symptoms) in publicly organised screening programmes...
  27. pmc Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study
    Britta Tendal
    Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMJ 339:b3128. 2009
    ..To study the inter-observer variation related to extraction of continuous and numerical rating scale data from trial reports for use in meta-analyses...
  28. ncbi request reprint [Selective reporting of positive outcomes in randomised trials--secondary publication.. A comparison of protocols with published reports]
    Asbjørn Hróbjartsson
    H S Rigshopitalet, Det Nordiske Cochrane Center, University Health Network Toronto, Department of Medicine
    Ugeskr Laeger 167:3189-91. 2005
    ..Selective reporting of positive outcomes is associated with bias...
  29. pmc Adequacy of authors' replies to criticism raised in electronic letters to the editor: cohort study
    Peter C Gøtzsche
    Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Dept 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMJ 341:c3926. 2010
    ..To investigate whether substantive criticism in electronic letters to the editor, defined as a problem that could invalidate the research or reduce its reliability, is adequately addressed by the authors...
  30. ncbi request reprint Intravenous alpha-1 antitrypsin augmentation therapy: systematic review
    Peter C Gøtzsche
    Rigshospitalet, The Nordic Cochrane Centre, University of Copenhagen, Denmark
    Dan Med Bull 57:A4175. 2010
    ..14 to 2.14; p = 0.03) over the total course of the trials. Augmentation therapy with alpha-1 antitrypsin cannot be recommended in view of the lack of evidence of clinical benefit and the cost of treatment...
  31. ncbi request reprint [Better reporting of harms in randomized trials: an extension of the CONSORT statement]
    Peter C Gøtzsche
    Det Nordiske Cochrane Center, H S Rigshospitalet, Kobenhavn
    Ugeskr Laeger 167:1520-2. 2005
  32. pmc Ghost authorship in industry-initiated randomised trials
    Peter C Gøtzsche
    Nordic Cochrane Centre, Copenhagen, Denmark
    PLoS Med 4:e19. 2007
    ..The prevalence and nature of ghost authorship in industry-initiated randomised trials is not known...
  33. ncbi request reprint Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection
    Helle Krogh Johansen
    Department of Clinical Microbiology, H S Rigshospitalet, Copenhagen, Denmark
    Pediatr Pulmonol 37:427-32. 2004
    ..aeruginosa lung infection improved with time (P = 0.008). Our study shows that CF patients who are treated intensively have lower antibody responses and longer survival after acquisition of chronic P. aeruginosa lung infection...
  34. ncbi request reprint [Albumin or physiologic saline to hypovolemic intensive care patients?]
    Peter C Gøtzsche
    H S Rigshospitalet, Det Nordiske Cochrane Center
    Ugeskr Laeger 166:3835. 2004
  35. ncbi request reprint [What is the effect of placebo interventions? A systematic review of randomized clinical trials with placebo treated and untreated patients]
    Asbjørn Hróbjartsson
    Afdeling for Medicinsk Videskabsteori, Københavns Universitet, Panum Instituttet, DK 2200 København N
    Ugeskr Laeger 164:329-33. 2002
    ..Placebo treatments have been reported to help patients with many diseases, but the quality of the evidence supporting this belief has not been rigorously evaluated...
  36. ncbi request reprint Powerful spin in the conclusion of Wampold et al.'s re-analysis of placebo versus no-treatment trials despite similar results as in original review
    Asbjørn Hróbjartsson
    Hróbjartsson, The Nordic CochraneCentre, Rigshospitalet, Department 7112, Blegdamsvej 9, DK 2100 Copenhagen Ø
    J Clin Psychol 63:373-7. 2007
    ..95 (95% confidence interval = 0.88-1.02) versus odds ratio 0.99 (95% confidence interval = 0.81-1.23). Thus, B. E. Wampold et al.'s conclusion was not substantiated by their data, and is best characterized as powerful spin. ...
  37. ncbi request reprint Data extraction errors in meta-analyses that use standardized mean differences
    Peter C Gøtzsche
    Nordic Cochrane Centre, Rigshospitalet, Copenhagen Ø, Denmark
    JAMA 298:430-7. 2007
    ..It is not known how reliable such meta-analyses are...
  38. ncbi request reprint [Paracetamol has the same effect as non-steroidal anti-inflammatory agents in acute musculoskeletal injuries]
    Peter C Gøtzsche
    Afdeling 7112, H S Rigshospitalet, Det Nordiske Cochrane Center, København Ø
    Ugeskr Laeger 168:1981-2. 2006
  39. ncbi request reprint [COX-2 inhibitors and other non-steroidal anti-inflammatory agents--what is their future?]
    Peter C Gøtzsche
    Afdeling 7112, H S Rigshospitalet, Det Nordiske Cochrane Center, København Ø
    Ugeskr Laeger 168:1972-4. 2006
    ..These drugs have likely caused the deaths of thousands of patients. The use of all NSAIDs should be restricted as much as possible. Drug trials should be a public enterprise...
  40. pmc Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions
    Anders W Jørgensen
    The Nordic Cochrane Centre, Department 3343, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMC Med Res Methodol 8:60. 2008
    ..However, these studies have been restricted to certain medical specialities. We compared all industry-supported meta-analyses of drug-drug comparisons with those without industry support...
  41. pmc Believability of relative risks and odds ratios in abstracts: cross sectional study
    Peter C Gøtzsche
    Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
    BMJ 333:231-4. 2006
    ..To compare the distribution of P values in abstracts of randomised controlled trials with that in observational studies, and to check P values between 0.04 and 0.06...
  42. ncbi request reprint [Constraints on publication rights in industry-initiated clinical trials--secondary publication]
    Peter C Gøtzsche
    H S Rigshospitalet, Det Nordiske Cochrane Center, DK 2100 København Ø
    Ugeskr Laeger 168:2467-9. 2006
    ..These facts were not noted in any of the trial reports. We found similar constraints on publication rights in 44 protocols from 2004. This tight sponsor control over industry-initiated trials should be changed...
  43. ncbi request reprint Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies
    Asbjørn Hróbjartsson
    The Nordic Cochrane Centre, Rigshospitalet, Denmark
    J Clin Epidemiol 59:336-8; discussion 339-41. 2006
  44. ncbi request reprint [Breast cancer screening--two years after]
    Peter C Gøtzsche
    Det Nordiske Cochrane Center, København
    Ugeskr Laeger 164:204-6. 2002
  45. ncbi request reprint [Independent clinical trials are imperative]
    Peter C Gøtzsche
    H S Rigshospitalet, Det Nordiske Cochrane Center, København
    Ugeskr Laeger 167:1491-4. 2005
  46. pmc Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
    Anders W Jørgensen
    Nordic Cochrane Centre, Rigshospitalet, DK 2100 Copenhagen Ø, Denmark
    BMJ 333:782. 2006
    ..To compare the methodological quality and conclusions in Cochrane reviews with those in industry supported meta-analyses and other meta-analyses of the same drugs...
  47. pmc Searching for unpublished data for Cochrane reviews: cross sectional study
    Jeppe Bennekou Schroll
    The Nordic Cochrane Centre, Rigshospitalet, Dept 7810, Blegdamsvej 9, DK 2100 Copenhagen Ø, Denmark
    BMJ 346:f2231. 2013
    ..To describe the experiences of authors of Cochrane reviews in searching for, getting access to, and using unpublished data...
  48. doi request reprint General health checks in adults for reducing morbidity and mortality from disease
    Lasse T Krogsbøll
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    Cochrane Database Syst Rev 10:CD009009. 2012
    ..Also, screening leads to increased use of diagnostic and therapeutic interventions, which can be harmful as well as beneficial. It is, therefore, important to assess whether general health checks do more good than harm...
  49. pmc Readers as research detectives
    Peter C Gøtzsche
    The Nordic Cochrane Centre, Rigshospitalet, Dept 3343, Blegdamsvej 9, DK 2100, Copenhagen Ø, Denmark
    Trials 10:2. 2009
    ..The prevailing culture of secrecy and ownership to data is not in the best interests of patients...
  50. pmc Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents
    Anne K Due
    Nordic Cochrane Centre, Rigshospitalet, Dept, 7112, Blegdamsvej 9, DK 2100 København Ø, Denmark
    BMC Med Res Methodol 6:40. 2006
    ..We explored whether use of fungal infection-related mortality as outcome rather than total mortality leads to bias in trials of antifungal agents in cancer patients...
  51. doi request reprint General health checks in adults for reducing morbidity and mortality from disease
    Lasse T Krogsbøll
    Nordic Cochrane Centre, Rigshospitalet Department 7811, Blegdamsvej 9, 2100 København Ø, Denmark
    JAMA 309:2489-90. 2013
    ..Health checks may be associated with more diagnoses and more drug treatment. Morbidity was infrequently reported, as were most harms, such as use of diagnostic procedures...
  52. pmc Regular health checks: cross-sectional survey
    Christian Grønhøj Larsen
    Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
    PLoS ONE 7:e33694. 2012
    ..To investigate whether Danish providers of general health checks present a balanced account of possible benefits and harms on their websites and whether the health checks are evidence-based...
  53. doi request reprint Unbalanced reporting of benefits and harms in abstracts on rofecoxib
    Anders W Jørgensen
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    Eur J Clin Pharmacol 66:341-7. 2010
    ..From the patient's point of view, both effects are important and should be investigated and reported similarly. We studied how they have been reported over time...
  54. pmc What should be done to tackle ghostwriting in the medical literature?
    Peter C Gøtzsche
    Nordic Cochrane Centre, Copenhagen, Denmark
    PLoS Med 6:e23. 2009
    ..This debate examines how best to tackle ghostwriting in the medical literature from the perspectives of a researcher, an editor, and the professional medical writer...
  55. pmc Why we need easy access to all data from all clinical trials and how to accomplish it
    Peter C Gøtzsche
    Nordic Cochrane Centre, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark
    Trials 12:249. 2011
    ..I propose the contents of such legislation and of appropriate sanctions to hold accountable those who refuse to share their data...
  56. ncbi request reprint Relation between breast cancer mortality and screening effectiveness: systematic review of the mammography trials
    Peter C Gøtzsche
    The Nordic Cochrane Centre, Department 3343, Rigshospitalet, 2100 Copenhagen Ø, Denmark
    Dan Med Bull 58:A4246. 2011
    ..Given that the size of the bias was similar to the estimated screening effect, screening appeared ineffective...
  57. pmc Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study
    Jeppe Lerche la Cour
    Copenhagen Trial Unit, Rigshospitalet, Copenhagen University Hospital, DK 2100 Copenhagen, Denmark
    BMJ 341:c3653. 2010
    ..To assess if authors of randomised clinical trials convey the fact that they have used surrogate outcomes and discussed their validity...
  58. pmc Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups
    Matias Vested Madsen
    Nordic Cochrane Centre, Rigshospitalet, Department 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMJ 338:a3115. 2009
    ..To study the analgesic effect of acupuncture and placebo acupuncture and to explore whether the type of the placebo acupuncture is associated with the estimated effect of acupuncture...
  59. ncbi request reprint Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory
    Asbjørn Hróbjartsson
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    J Clin Epidemiol 62:967-73. 2009
    ..To compare the reporting on blinding in protocols and articles describing randomized controlled trials...
  60. doi request reprint Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia
    Karsten Juhl Jørgensen
    The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 7811, Copenhagen, Denmark, 2100
    Cochrane Database Syst Rev 2:CD004707. 2014
    ..Opportunistic fungal infections are a major cause of morbidity and mortality in neutropenic cancer patients and antifungal therapy is used both empirically and therapeutically in these patients...
  61. pmc Divine intervention? A Cochrane review on intercessory prayer gone beyond science and reason
    Karsten Juhl Jørgensen
    Dept 3343, The Nordic Cochrane Centre, Rigshospitalet, DK 2100 Copenhagen, Denmark
    J Negat Results Biomed 8:7. 2009
    ..The review fails to live up to the high standards required for Cochrane reviews...
  62. pmc Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention
    Lasse Theis Krogsbøll
    The Nordic Cochrane Centre, Rigshospitalet, Dept, 3343, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMC Med Res Methodol 9:1. 2009
    ..It is not known to which extent spontaneous improvement, effect of placebo and effect of active interventions contribute to the observed change from baseline, and we aimed at quantifying these contributions...
  63. pmc Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study
    Jeppe B Schroll
    Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Denmark
    BMC Med Res Methodol 11:22. 2011
    ....
  64. pmc Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
    Andreas Lundh
    Nordic Cochrane Centre, Rigshospitalet Dept, 3343, Blegdamsvej 9, DK 2100 Copenhagen Ø, Denmark
    BMC Med Res Methodol 8:22. 2008
    ..Assessing the risk of bias in individual studies in a systematic review can be done using individual components or by summarizing the study quality in an overall score...
  65. pmc Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study
    Karsten Juhl Jørgensen
    The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark
    BMC Med 5:12. 2007
    ..We wanted to determine if a similar imbalance occurs in scientific articles on mammography screening and if it is related to author affiliation...
  66. pmc Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study
    Julie Pildal
    Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
    BMJ 330:1049. 2005
    ....
  67. pmc Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review
    Gloria Cordoba
    Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, DK 2100 Copenhagen, Denmark
    BMJ 341:c3920. 2010
    ..To study how composite outcomes, which have combined several components into a single measure, are defined, reported, and interpreted...
  68. ncbi request reprint Physical activity for secondary prevention of disease. Systematic reviews of randomised clinical trials
    Katrine Karmisholt
    Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 København Ø, Denmark
    Dan Med Bull 52:90-4. 2005
    ..Physical activity is recommended for secondary prevention of several diseases but it is not always clear how reliable the evidence is...